In 2016, Inflexion provided minority funding to support the expansion of Medivet, a UK veterinary pet-care business. A successful partnership delivered strong acquisitive and organic growth, and Medivet was sold in 2021 to CVC Capital Partners.

  • Sector


  • Headquarters

    London, UK

  • Fund

    Partnership Capital

  • Investment date

    December 2016 - September 2021

  • Status



The company

Medivet is a pet-care business comprised of a community of vets, nurses and other related professionals operating a hub-and-spoke model of 18 main centres and over 300 first opinion practices. Medivet was founded in 1986 and is today recognised as a provider of very high levels of client service and patient care. The business is led by a team of veterinary surgeons with over 300 years’ collective experience.
The business has capitalised on industry deregulation that stimulated market consolidation, successfully expanding by acquiring practices across the UK. Medivet continues to grow as the £2bn UK vet industry is buoyed by rising propensity to source the best possible pet care, and supported by increasing insurance penetration.

The Inflexion investment

During the partnership, the business saw strong growth, and significantly increased its number of sites and employees through an ambitious programme of organic and M&A growth. Sites doubled to over 350 in both the UK and Europe, and headcount doubled to over 3,000. Most recently the company expanded into Europe with the acquisition of over 40 practices in Germany and Spain.

The Inflexion difference

Already expanding strongly, Medivet management were looking for a minority investor to help accelerate their growth plans. Inflexion’s understanding of the pet-care market gleaned through its investment in Kynetec combined with its extensive buy-and-build experience and willingness to provide minority funding made it a good fit for Medivet’s management.

Press releases